West Lafayette, IN, United States of America

G Patrick Stahly

This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Celgene Corporation, Bionevia Pharmaceuticals, Inc., The Broad Institute, Inc.. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: G Patrick Stahly. Retrieved from https://idiyas.com/inventor/g-patrick-stahly-rs05v06a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 78.9

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 36(Granted Patents)

Company Filing History:

Bionevia Pharmaceuticals, Inc.

patents

3 out of 486

The Broad Institute, Inc.

Miravant Pharmaceuticals, Inc.

patents

6. 1 out of 2,785

Purdue Research Foundation

8. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...

Areas of Expertise:

Solid Forms

Cocrystals

Epalrestat

Tacedinaline

High Energy Forms

Compositions

Screening Methods

Coformers

Isoindoline

Dioxopiperidine

Pharmaceutical Chemistry

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11406629 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2022-08-09),

2. 10835522 - Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2020-11-17),

3. 10464912 - Choline cocrystal of epalrestat (2019-11-05),

4. 10376503 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2019-08-13),

5. 9974780 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2018-05-22),

6. 9968627 - Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof (2018-05-15),

7. 9808450 - Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof (2017-11-07),

8. 9695146 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2017-07-04),

9. 9611234 - Choline cocrystal of epalrestat (2017-04-04),

10. 9447056 - Solid forms of epalrestat (2016-09-20),

11. 9266822 - Solid forms of tacedinaline (2016-02-23),

12. 8906948 - Choline cocrystal of epalrestat (2014-12-09),

13. 8729130 - Methods of using novel solid forms of tacedinaline (2014-05-20),

14. 8697735 - Solid forms of epalrestat (2014-04-15),

15. 8691875 - Solid forms of tacedinaline (2014-04-08),

Title: G Patrick Stahly: A Pioneer in Pharmaceutical Innovations

Introduction

G Patrick Stahly is an accomplished inventor based in West Lafayette, IN, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio comprising 19 patents, he has been instrumental in developing innovative solid forms utilized in various medical applications.

Latest Patents

Among his latest patents, Stahly has developed novel solid forms including 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer. These patents focus on pharmaceutical compositions that incorporate these solid forms, which are particularly effective in treating, preventing, and managing a range of disorders. The cocrystals he has engineered enhance the performance of pharmaceutical products by improving their solubility and bioavailability.

Career Highlights

Stahly has previously worked with notable companies such as Celgene Corporation and Bionevia Pharmaceuticals, Inc. His career has been marked by a commitment to advancing pharmaceutical sciences, leading to breakthroughs in medication formulations and therapeutic applications.

Collaborations

Throughout his career, Stahly has collaborated with key figures in the industry, including David Thomas Jonaitis and Ho-Wah Hui. These partnerships have fostered innovation by combining expertise across diverse areas of pharmaceutical research and development.

Conclusion

G Patrick Stahly's contributions to the field of pharmaceuticals through his inventions and patents continue to influence medical advancements. His work not only demonstrates innovative thinking but also underscores the importance of collaboration in achieving groundbreaking results in healthcare solutions.

Profile summary based on public USPTO records.